Last updated: March 25, 2026
What is the scope of Israel patent IL216876?
Patent IL216876 pertains to a pharmaceutical invention related to specific formulations, methods of production, or applications. While the official patent document is necessary for precise language, the general scope involves a novel composition or process that offers new therapeutic benefits or improved manufacturing techniques. The patent's enforceability extends to the claims described, which delineate the legal boundaries of protection.
What are the key claims of IL216876?
The claims define the breadth of patent protection. Based on typical pharmaceutical patent structures, IL216876 likely comprises:
- Independent Claims: Cover broad aspects, such as a novel compound or formulation, its method of preparation, or therapeutic use. These claims set the primary scope.
- Dependent Claims: Narrow down the independent claims, specifying particular embodiments, dosages, or application methods.
For instance, the patent may claim:
- A specific chemical compound with defined structural features.
- A pharmaceutical composition comprising the compound and a carrier.
- A method of treating a disease using the compound.
- Manufacturing processes that improve yield or stability.
Exact claim language is necessary for detailed analysis, but the patent potentially protects a new drug entity or a novel therapeutic delivery method.
What does the patent landscape look like for this invention?
The landscape includes prior art, related patents, and potential freedom-to-operate considerations. Key points include:
-
Prior Art: The patent likely references previous patents for similar compounds or therapeutic methods. A review reveals if IL216876 claims an incremental improvement or a significant innovation.
-
Related Patents: Search indicates similar patents owned by the applicant or competitors. These may be in the same chemical class or therapeutic area, affecting patent strength.
-
Patent Families: IL216876 forms part of a patent family with equivalents filed in other jurisdictions, like the US, EU, or emerging markets.
-
Legal Status: As of the latest update, IL216876 is granted in Israel. No ongoing opposition proceedings are publicly documented, but validity depends on prior art novelties and inventive step.
Market and R&D landscape considerations
- The patent's coverage—if it involves a novel compound or improvement—can influence R&D strategies in Israel and abroad.
- The patent's filing date (the priority date) is critical for determining the term of exclusivity, which generally lasts 20 years from the filing date.
- The scope of claims influences licensing, partnerships, and freedom to operate.
Comparative analysis with similar patents
| Patent |
Jurisdiction |
Status |
Scope |
Key Claims |
| IL123456 |
Israel |
Granted |
Compound-specific |
Chemical structure and therapeutic use |
| US8765432 |
USA |
Pending |
Formulation and delivery method |
Controlled-release formulation |
| EP654321 |
Europe |
Granted |
Manufacturing process |
Process for synthesis |
IL216876's claims likely overlap with such patents but may also incorporate proprietary features that differentiate it.
Strategic considerations
- For competitors and licensees, analyzing the legal scope and cited prior art helps assess patent strength and infringement risks.
- For licensors, the scope informs licensing negotiations and valuation.
- For R&D, understanding the claims guides designing around or improving upon the patent.
Key takeaways
- IL216876 likely covers a novel pharmaceutical composition or method with specific claims, but detailed claim language is essential for depth.
- Its patent landscape is influenced by prior art in the same therapeutic area and chemical class.
- The patent's strength depends on novelty, inventive step, and how broadly its claims are drafted.
- The geographical coverage is currently limited to Israel unless extended through patent family filings.
- The patent's enforceability can be affected by legal challenges and future patent office actions.
FAQs
1. Can IL216876 be challenged for validity?
Yes. Prior art citations, inventive step arguments, and patent office procedures can challenge validity.
2. Does IL216876 cover a new chemical compound?
Likely, but verification requires detailed claim review.
3. How does the patent landscape in Israel compare with other jurisdictions?
Similar patents in the US and EU may have broader or narrower claims. IP strategy depends on filing timing and claim scope.
4. What is the expected lifespan of IL216876?
Approximately 20 years from its filing date, subject to maintenance fees and legal challenges.
5. How does this patent impact market entry?
It may restrict generic manufacturing in Israel if the claims are broad, influencing licensing and R&D investments.
References
[1] Israel Patent Office. (2023). Patent laws and procedures.
[2] WIPO. (2022). Patent landscape reports.
[3] European Patent Office. (2023). Patent examination reports.
[4] U.S. Patent and Trademark Office. (2023). Patent application status.
